z-logo
Premium
Low‐dose 5‐fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms – results of a non‐interventional study
Author(s) -
Reinhold U.,
Hadshiew I.,
Melzer A.,
Prechtl A.
Publication year - 2017
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.13935
Subject(s) - medicine , actinic keratoses , tolerability , fluorouracil , dermatology , actinic keratosis , cheek , surgery , adverse effect , chemotherapy , basal cell
Background As an in situ carcinoma, actinic keratoses should be treated early. Previous studies on the efficacy of a low‐dose 0.5% 5‐fluorouracil solution in combination with 10% salicylic acid (low‐dose 5‐ FU / SA ) are mostly related to lesions appearing on the head and face. In contrast, actinic keratoses ( AK ) lesions of the upper extremities are considered to be difficult to treat. Objective The efficacy of low‐dose 5‐ FU / SA in the treatment of actinic keratoses on the hands and/or forearms was studied for the first time in this non‐interventional study ( NIS ) under practical conditions in a large patient population. In addition to the clinical course during therapy and a follow‐up period, the length of application and adherence were documented. Methods As part of this NIS , 649 patients with AK were treated at 207 centres with low‐dose 5‐ FU / SA . The data of the study were recorded at baseline, optionally during an intermediate examination, at the end of therapy and during a final assessment. Results The average number of AK lesions decreased during the entire observation period by 92%. Side‐effects were documented only rarely in the form of local skin reactions (2%). The attending physicians assessed the efficacy, tolerability and safety of the therapy as being predominantly very good or good (in each case ≥90%). Conclusion AK lesions on the hands and/or forearms were effectively treated with low‐dose 5‐ FU / SA under routine conditions in dermatological practice and the treatment was well tolerated.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom